Journal
INTERNATIONAL JOURNAL OF NEUROSCIENCE
Volume 125, Issue 10, Pages 717-725Publisher
TAYLOR & FRANCIS LTD
DOI: 10.3109/00207454.2014.982795
Keywords
Parkinson's disease; neuroinflammation; inflammation; dopamine; microglia; nigrostriatal; alpha-synuclein; ageing
Categories
Funding
- Royal College of Surgeons of England
Ask authors/readers for more resources
Neuroinflammation in Parkinson's disease [PD] is a process that occurs alongside the loss of dopaminergic neurons, and is associated with alterations to many cell types, most notably microglia. This review examines the key evidence contributing to our understanding of the role of inflammation-mediated degeneration of the dopaminergic (DA) nigrostriatal pathway in PD. It will consider the potential role inflammation plays in tissue repair within the brain, inflammation linked gene products that are associated with sporadic Parkinsonian phenotypes (alpha-synuclein, Parkin and Nurr 1), and developing anti-inflammatory drug treatments in PD. With growing evidence supporting the key role of neuroinflammation in PD pathogenesis, new molecular targets are being found that could potentially prevent or delay nigrostriatal DA neuron loss. Hence, this creates the opportunity for disease modifying treatment, to currently what is an incurable disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available